Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Clinical trial NCT01988103 · COMPLETED

Trial details

NCT number: NCT01988103
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Psoriatic Arthritis Psoriasis Arthropatica

Start date: 2013-07-09
Primary completion: 2014-11-20
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.